Options Trading News

February 14, 2013  Thu 5:16 AM CT

Shares of Ziopharm Oncology gapped higher this week, and option traders are betting on even larger gains ahead.  

optionMONSTER's Heat Seeker program showed heavy buying in the May 7 calls, including one big block of 3,500 contracts for $0.70. Open interest was a mere 145 contracts coming in today, so someone obviously believes that this $245,000 investment will yield big returns.

Long calls lock in the price investors must pay to buy a stock. They can generate nice leverage in the event of a rally but will expire worthless if the shares climb above the $7 strike price by mid-May. (See our Education section)

Ziopharm began the week as a $4 stock. Now, after a presentation at an industry conference and Phase III trials of Palifosfamide treatment on soft-tissue sarcoma looking extremely positive, shares are closer to $5.

Palifosfamide belongs to a group of chemotherapy drugs called alkylating agents, which halt tumor growth by binding to cancer-cell DNA and interfering with its function. Full results are expected by the end of this quarter.

ZIOP ended yesterday's session up 0.21 percent to $4.70. Calls dominated its option activity, outnumbering puts by a bullish 15-to-1 ratio.

Disclosure: I own ZIOP call spreads.

(A version of this post appeared on InsideOptions Pro yesterday.)
Share this article with your friends

Related Stories


Notable option activity in equities

November 13, 2015

Nearing the halfway mark in today's session, here are the individual equity names with unusual option activity on optionMONSTER's ActionTracker data system.


Traders wait for Ziopharm breakout

November 9, 2015

The developer of cancer drugs is trying to push through the level where it peaked in March and August as investors await initial results from two early-stage trials later this year.



The fastest money in the market
View full report »

Premium Services

Education & Strategy

The art of trading

As I stated in last week's article, a break out or a break down needs to have a couple things happen before it is considered a confirmed break out or break down. The only problem is that in today's market where things move much more quicker than they did just a few years ago, two days could wind up being the majority of the expected movement, if not the whole movement.

View more education articles »